InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-25.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Johnson Kevin C, Director. Director active across 1 company, notably Neogenomics INC. In total, 4 filings have been published. History available since 2 June 2021. The latest transaction was filed on 22 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
3,334 shares@ US$7.2750.0% of flowCommon StockSEC:0001077183-21-000259
3,334 shares@ US$7.270.0020% mcap50.0% of flowCommon StockSEC:0001077183-21-000259:0
3,081 shares0Common StockSEC:0001077183-21-000160:0
3,081 shares0Common StockSEC:0001077183-21-000160
4 of 4 declarations
About Johnson Kevin C
Johnson Kevin C is a Board Member at NEOGENOMICS INC. He contributes to the governance of the company by providing strategic advice and overseeing development initiatives.
